These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3664317)
1. Evaluation of topical therapy with silver-kaolin (Argostop) in an experimental model of burn wound sepsis. Linares HA; Fader RC Burns Incl Therm Inj; 1987 Aug; 13(4):281-5. PubMed ID: 3664317 [TBL] [Abstract][Full Text] [Related]
2. Topical silver treatment after escharectomy of infected full thickness burn wounds in rats. Chu CS; McManus AT; Mason AD; Pruitt BA J Trauma; 2005 May; 58(5):1040-6. PubMed ID: 15920422 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of silver nylon dressings with weak direct current on Pseudomonas aeruginosa-infected burn wounds. Chu CS; McManus AT; Pruitt BA; Mason AD J Trauma; 1988 Oct; 28(10):1488-92. PubMed ID: 3172311 [TBL] [Abstract][Full Text] [Related]
4. Nano-silver modified porcine small intestinal submucosa for the treatment of infected partial-thickness burn wounds. Zhang Y; Xu J; Chai Y; Zhang J; Hu Z; Zhou H Burns; 2019 Jun; 45(4):950-956. PubMed ID: 30595540 [TBL] [Abstract][Full Text] [Related]
5. Wound contraction effects and antibacterial properties of Tualang honey on full-thickness burn wounds in rats in comparison to hydrofibre. Khoo YT; Halim AS; Singh KK; Mohamad NA BMC Complement Altern Med; 2010 Sep; 10():48. PubMed ID: 20815896 [TBL] [Abstract][Full Text] [Related]
6. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. Sawhney CP; Sharma RK; Rao KR; Kaushish R Burns; 1989 Dec; 15(6):403-6. PubMed ID: 2516445 [TBL] [Abstract][Full Text] [Related]
7. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds. Boekema BK; Pool L; Ulrich MM Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845 [TBL] [Abstract][Full Text] [Related]
8. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds. Gray JH; Henry DA; Forbes M; Germann E; Roberts FJ; Snelling CF Burns; 1991 Feb; 17(1):37-40. PubMed ID: 2031672 [TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection. Inman RJ; Snelling CF; Roberts FJ; Shaw K; Boyle JC Burns Incl Therm Inj; 1984 Oct; 11(1):35-40. PubMed ID: 6391611 [TBL] [Abstract][Full Text] [Related]
10. Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit. Koo DS; Zhen S; Zhen ZD; Shi XW; Xiang SJ Burns; 1989 Jun; 15(3):193-6. PubMed ID: 2757770 [TBL] [Abstract][Full Text] [Related]
11. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound. Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745 [TBL] [Abstract][Full Text] [Related]
13. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis. Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223 [TBL] [Abstract][Full Text] [Related]
14. Comparison of battlefield-expedient topical antimicrobial agents for the prevention of burn wound sepsis in a rat model. Kauvar DS; Acheson E; Reeder J; Roll K; Baer DG J Burn Care Rehabil; 2005; 26(4):357-61. PubMed ID: 16006845 [TBL] [Abstract][Full Text] [Related]
15. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. Wang XW; Wang NZ; Zhang OZ; Zapata-Sirvent RL; Davies JW Burns Incl Therm Inj; 1985 Feb; 11(3):197-201. PubMed ID: 3986644 [TBL] [Abstract][Full Text] [Related]
17. Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Hemmila MR; Mattar A; Taddonio MA; Arbabi S; Hamouda T; Ward PA; Wang SC; Baker JR Surgery; 2010 Sep; 148(3):499-509. PubMed ID: 20189619 [TBL] [Abstract][Full Text] [Related]
18. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Subrahmanyam M Burns; 1998 Mar; 24(2):157-61. PubMed ID: 9625243 [TBL] [Abstract][Full Text] [Related]
19. Patient tolerance study of topical chlorhexidine diphosphanilate: a new topical agent for burns. Miller LM; Loder JS; Hansbrough JF; Peterson HD; Monafo WW; Jordan MH Burns; 1990 Jun; 16(3):217-20. PubMed ID: 2383364 [TBL] [Abstract][Full Text] [Related]
20. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents. Modak SM; Fox CL Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]